Keith Humphreys
Independent Non-Executive DirectorDr. Keith Humphreys, OBE, PhD, is Independent Non-Executive Director of Supernus Pharmaceuticals, Inc. from 2026. He is Independent Non-Executive Director of Supernus, Inc. (Earlier known as Indivior Pharmaceuticals, Inc.) and had been its Non-Executive Director from 2023 and served as its Independent Non-Executive Director from November 09, 2023 until 2023. Dr. Humphreys is an Esther Ting Memorial Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. He was previously a Senior Policy Advisor in the White House Office of National Drug Control Policy in the Obama Administration and is an Honorary Professor of Psychiatry at the Institute of Psychiatry, King's College, London. Dr. Humphreys was awarded an OBE in September 2022 for his services to science and policy on addiction. Dr. Humphreys holds a BA in Psychology from Michigan State University and an AM in Clinical/Community Psychology and PhD in Psychology from the University of Illinois.
Positions
- Company NameSupernus, Inc.Stock CodeSUPNPositionIndependent Non-Executive DirectorColleagues
- CHChristian HeidbrederChief Scientific Officer
- SAStuart Anthony KingsleyIndependent Non-Executive Chair
- JAJack A. KhattarPresident, CEO & Director
- TCTimothy C. DecSenior VP & CFO
- JTJason ThompsonVice President of Investor Relations
- KLKevin L. EspinozaChief Integrity & Compliance Officer
- JTJuliet ThompsonLead Independent Director
- MPMark P. StejbachIndependent Non-Executive Director
